prof. dr. M.J. Postma
Prof Maarten J Postma (29/01/1960) holds the chair Global Health Economics at the University Medical Center Groningen (UMCG) and the faculty of Economics & Business, both at the University of Groningen and is director of UMCG’s research institute SHARE. Also, he is Prof in Pharmacoeconomics at the Departments of Pharmacy at the University of Groningen, Pharmacology at the Airlangga University (Surabaya, Indonesia) and Pharmaceutical Care Innovation at Universitas Padjadjaran (Bandung, Indonesia). He did his MSc in econometrics and his PhD in health economics. He specifically leads a team of 70 staff, PhD and post-doc researchers in health- and pharmacoeconomics, contributing to many international research networks and scientific communications. Research areas comprise cost-effectiveness methods, for example, in vaccinology, transfusion science, prevention of (complications) of chronic diseases, orphan drugs and personalized medicine, inclusive gene therapies. He serves (served) on various committees advising the Dutch government on reimbursement of drugs and vaccines (CVZ/ZiNL and Health Council). Also, he is advisor to various health-economics consultancy companies and pharmaceutical companies worldwide, Ministries of Health in neighbouring countries, member of editorial boards of various scientific journals (for example, Value in Health, Frontiers in Pharmacology, Vaccines and PLoS One), on advisory boards for pharmaceutical companies, expert consultant for WHO and member of WHO’s SAGE-committees. He is a member of UK’s Joint Committee of Vaccination & Immunization and advisor to the All Wales Medicines Strategy Group (Grwp Strategaeth Meddyginiaethau Gymru Gyfam). He is specialized in the role of pharmacoeconomics/health economics in the reimbursement process. He has approximately 500 MEDLINE-publications, an H-factor of 60 and extensive teaching/lecturing experience (Groningen, Amsterdam, Utrecht, Heidelberg, Bielefeld, Ankara, Sofia, various universities in Indonesia, JoBurg, Moscow and Hanoi). So far, he attracted 10 EU-projects, 10 WHO-projects, various national projects from the National Institute of Public Health and the MoH, projects from NGOs and multiple projects from pharma, aggregating to over 15 million EUR in the last decade. His research often features in newspapers and Dutch television. He is involved in 5 spin-off consultancy companies from the University in various roles.
|Last modified:||08 July 2020 11.23 p.m.|